List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 814 studies with search of: Open Studies | "Hypoglycemic Agents"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Vitamin C;   Drug: glyburide
2 Recruiting Gestational Diabetes: Insulin or Oral Hypoglycemic Agents?
Condition: Gestational Diabetes Mellitus
Interventions: Drug: Insulin;   Drug: Metformin, glyburide and insulin
3 Unknown † DARE: Diabetes in cArdiac REhabilitation
Conditions: Type 2 Diabetes Mellitus;   Coronary Artery Disease
Interventions: Other: Conventional antidiabetic treatment;   Other: Intensive insulin treatment
4 Recruiting Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty
Conditions: Type 2 Diabetes Mellitus;   Peripheral Vascular Disease
Intervention: Drug: Insulin glargine plus insulin analogues
5 Recruiting Optimized Glycemic Control in Heart Failure Patients With DM2:"Effect on Left Ventricular Function and Skeletal Muscle"
Conditions: Type 2 Diabetes;   Heart Failure
Interventions: Other: all antidiabetic drugs will be appliable;   Other: no intervention
6 Recruiting Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Biological: MSC
7 Recruiting Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: HOE 901 - Insulin glargine;   Drug: HOE901 - Insulin glargine-new formulation
8 Recruiting A Study in Adults With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2963016;   Drug: Lantus;   Drug: Oral Antihyperglycemic Medications (OAMs)
9 Recruiting Prospective Controlled Trial on Surgical Treatment of Type 2 Diabetes Patients With BMI 25-30 by Means of Biliopancreatic Diversion
Conditions: Type 2 Diabetes Mellitus;   Bariatric Surgery;   Biliopancreatic Diversion
Interventions: Procedure: biliopancreatic diversion;   Drug: antidiabetics
10 Recruiting The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus Ribavirin
Condition: Chronic Hepatitis C
Interventions: Drug: Pioglitazone;   Drug: Acarbose;   Drug: Metformin
11 Not yet recruiting Proteus Sustained Behavior Change Study
Condition: Type 2 Diabetes Mellitus
Interventions: Device: Proteus Sustained Behavior Change system;   Drug: Regularly prescribed diabetes medicines (metformin, sulfonylureas, thiazolidinediones, DPP-IV inhibitors, alpha-glucosidase inhibitors)
12 Recruiting Periprocedural Glycemic Control in Patients Undergoing Coronary Angiography
Conditions: Diabetes Mellitus;   Coronary Artery Disease
Intervention: Other: hold hypoglycemic meds
13 Recruiting Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery
Condition: Focus of Study is Cognitive Function During and After Hypoglycemia and to See if This Correlates Better With Blood or Interstitial Glucose Concentration.
Interventions: Procedure: euglycemic and hypoglycemic clamp;   Procedure: interstitial fluid measurement for glucose concentration;   Device: continuous glucose monitor
14 Recruiting Development of A Novel Anti-Hyperglycemic Agent
Condition: Diabetes
Interventions: Drug: Cyclo-Z;   Drug: Placebo
15 Not yet recruiting Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients on Oral Antidiabetic Medication
Conditions: Type 2 Diabetes Mellitus (Non-insulin-dependent);   Iron Deficiency Anemia
Interventions: Drug: ferric carboxymaltose;   Drug: NaCl (0,9%)
16 Recruiting Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: placebo;   Drug: exenatide
17 Unknown † The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark
Conditions: Type 2 Diabetes;   Hypercholesterolemia
Interventions: Dietary Supplement: Cinnamonforce;   Dietary Supplement: Placebo
18 Unknown † A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Repaglinide
19 Recruiting The Role of Endocannabinoids in Insulin Production and Action
Conditions: Glucose Metabolism;   Insulin Resistance
Interventions: Drug: CP-945,598;   Procedure: Hypoglycemic Clamp;   Procedure: Euglycemic-Hyperinsulinemic Clamp
20 Recruiting Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4
Condition: Type 2 Diabetes
Intervention: Other: Hyperinsulinemic Hypoglycemic Clamp

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services